MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Health Decisions
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Health Decisions Expands the Agile Clinical Network with the Addition of African CRO ClinResearch - International research network’s continued growth strengthens its aim to raise standards of efficiency and quality for global clinical trials
Health Decisions Expands the Agile Clinical Network with the Addition of African CRO ClinResearch

 

NewswireToday - /newswire/ - Durham, NC, United States, 2010/04/13 - International research network’s continued growth strengthens its aim to raise standards of efficiency and quality for global clinical trials.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Health Decisions, a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, welcomes South Africa-based CRO ClinResearch to the Agile Clinical Network—a community of research partners formed to eliminate the information gaps and prolonged timelines inherent to complex global studies.

As the newest Agile Network partner, ClinResearch joins a global infrastructure of free-standing yet integrated research modules, each of which is held to stringent standards of research quality and regulatory compliance, yet is individually empowered to affect operational efficiency and capitalize on region-specific cultural expertise. To ensure consistency and optimal performance across the network, partners are required to undergo training and certification in Agile Clinical Development—an adaptive research methodology fine-tuned by Health Decisions to cut timelines, increase transparency, and promote success for multinational programs.

“Things move more quickly and smoothly within the network model,” said Deidré Marais, owner and clinical operations manager at ClinResearch. “The Agile methodology ensures that each network partner functions as part of a cohesive whole for even the most complex, geographically dispersed global studies. At the same time, immediate access to localized operational metrics lets us proactively manage the investigators and patient populations with whom we work directly, leveraging our familiarity with the study environment in even more valuable ways. It would be very difficult for an individual CRO to exercise this level of streamlined productivity, regardless of its size or the quantity and locations of its offices.”

According to Rick Farris, chief operations officer at Health Decisions, the company’s alignment with ClinResearch will enrich the Agile Network’s geographic and cultural scope and present promising opportunities to cost-effectively engage diverse, unique patient populations. “ClinResearch demonstrates an impressive record of successful trials in eight African countries, and is highly familiar with the culture and regulatory standards of several others,” he said. “In addition, ClinResearch has relationships with the area’s highest quality investigators and researchers, making the company an invaluable asset to our mission of improving standards of success for global clinical programs.”

About Health Decisions
Health Decisions (HealthDec.com) is a global clinical research organization (CRO) committed to helping drug and device companies achieve greater success. Our sponsors rely on us to help them prove the value of their pipelines both faster and with the smartest possible allocation of funds. Through Agile Clinical Development—a strategic combination of adaptive design and adaptive operations—Health Decisions optimizes every facet of clinical research from design protocol to the most detailed day-to-day management, so sponsors can make the most of competitive market opportunities.

Health Decisions is headquartered in Durham, NC, with over twenty years of experience helping sponsors achieve success in Phase I-IV trials across all major therapy areas. For more information, please visit the company's website at the URL accompanying this press release.

About ClinResearch
ClinResearch is a South Africa-based contract research organization (CRO) with expertise in conducting clinical trials in South Africa and surrounding countries. The company offers its pharmaceutical and biotechnology clients a full range of Phase I – IV services in areas including regulatory affairs; clinical monitoring; investigator site selection and management; drug, supply and equipment sourcing, distribution and storage; and patient document translation and compilation.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Health Decisions

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Health Decisions Expands the Agile Clinical Network with the Addition of African CRO ClinResearch

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Katie Hendrick - HealthDec.com 
919-967-1111 x116 khendrick[.]HealthDec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Health Decisions securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Health Decisions / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  JobsWare.com





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)